Northern Trust’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Northern Trust’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-5,273	Closed	-$291K	–	4275
2015 Q1	$291K	Buy	5,273 +353	+7%	+$19.1K	﹤0.01%	3762
2014 Q4	$247K	Buy	+4,920	New	+$241K	﹤0.01%	3751

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TAM

Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return

Quantitative Advantage Minnetonka, Minnesota $689M AUM 6.25% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return

Northern Trust's PBE Position: Q2 2015 in Review

Northern Trust sold out of Invesco Biotechnology & Genome ETF (PBE) in Q2 2015, closing a stake of 5,273 shares — an estimated $291K sold.

Northern Trust first reported a position in PBE in Q4 2014 and held it in 2 quarters. The position peaked at $291K in Q1 2015. 86 funds tracked by Wall St. Rank hold PBE as of Q2 2015.

Northern Trust reported no remaining Invesco Biotechnology & Genome ETF position as of Q2 2015 after selling out during the quarter.
Northern Trust sold 5,273 Invesco Biotechnology & Genome ETF shares in Q2 2015, an estimated $291K.
Northern Trust first reported a position in Invesco Biotechnology & Genome ETF in Q4 2014 and held it in 2 quarters.
Northern Trust's Invesco Biotechnology & Genome ETF position peaked at $291K in Q1 2015.
86 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2015.

Based on Northern Trust's 13F filing for Q2 2015, filed 13 Aug 2015.